| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.1M | +0.0% |
| R&D Expense | $62.6M | +71.4% |
| SG&A Expense | $25.7M | +110.0% |
| Operating Income | -$88.2M | -85.3% |
| Net Income | -$83.9M | -71.3% |
| EPS (Basic) | -$2.13 | +46.1% |
| EPS (Diluted) | -$2.13 | +46.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $461.4M | +298.4% |
| Short-term Investments | $112.8M | -44.6% |
| Accounts Receivable | $1.5M | — |
| Current Assets | $577.8M | +78.4% |
| Total Assets | $594.0M | +82.3% |
| Current Liabilities | $15.1M | +39.2% |
| Long-term Debt | $1.9M | -20.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$64.3M | -63.7% |
| Capital Expenditures | $2.2M | +211.6% |
| Investing Cash Flow | $87.5M | +142.8% |
| Financing Cash Flow | $322.3M | +7.3% |
| Free Cash Flow | -$66.6M | -66.4% |
| Total Liabilities |
| $27.0M |
| +110.8% |
| Stockholders' Equity | $567.0M | +81.2% |